{"date":"2025-12-05","count":15,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6645-2025-12-05-2152-q59nyy","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2025-12-05","time":"21:52:06","subject":"本公司受邀參加臺灣證券交易所舉辦之「創新引領未來：多元技術與市場拓展之路」 創新板公司法人說明會","clause":"第12款","fact_date":"2025-12-08","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2025-12-05 21:52，「本公司受邀參加臺灣證券交易所舉辦之「創新引領未來：多元技術與市場拓展之路」 創新板公司法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2025-12-05-2025-tw0lp0","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2025-12-05","time":"20:25:24","subject":"代重要子公司Lotus International Pte.Ltd.公告2025年股東臨時會重要決議事項","clause":"第18款","fact_date":"2025-12-05","cite_as":"公開資訊觀測站重大訊息：美時（1795），2025-12-05 20:25，「代重要子公司Lotus International Pte.Ltd.公告2025年股東臨時會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2025-12-05-2025-n0zddv","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2025-12-05","time":"20:25:06","subject":"代重要子公司Lotus International Pte. Ltd.公告減資事宜","clause":"第11款","fact_date":"2025-12-05","cite_as":"公開資訊觀測站重大訊息：美時（1795），2025-12-05 20:25，「代重要子公司Lotus International Pte. Ltd.公告減資事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2025-12-05-2024-13o0a95","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2025-12-05","time":"20:24:48","subject":"代重要子公司Lotus International Pte.Ltd.公告召開2025年股東臨時會","clause":"第17款","fact_date":"2025-12-05","cite_as":"公開資訊觀測站重大訊息：美時（1795），2025-12-05 20:24，「代重要子公司Lotus International Pte.Ltd.公告召開2025年股東臨時會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6917-2025-12-05-1716-10i02gm","company_id":"6917","company":"竟天","market":"興櫃","industry":"生技醫療","date":"2025-12-05","time":"17:16:34","subject":"本公司依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第二款及第三款辦理公告","clause":"第20款","fact_date":"2025-12-05","cite_as":"公開資訊觀測站重大訊息：竟天（6917），2025-12-05 17:16，「本公司依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第二款及第三款辦理公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6917-2025-12-05-1716-17v2w4v","company_id":"6917","company":"竟天","market":"興櫃","industry":"生技醫療","date":"2025-12-05","time":"17:16:11","subject":"本公司依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第一款辦理公告","clause":"第20款","fact_date":"2025-12-05","cite_as":"公開資訊觀測站重大訊息：竟天（6917），2025-12-05 17:16，「本公司依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第一款辦理公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6730-2025-12-05-1630-1muo30n","company_id":"6730","company":"常廣","market":"上櫃","industry":"生技醫療","date":"2025-12-05","time":"16:30:32","subject":"公告本公司辦理股票初次上櫃過額配售內容","clause":"第44款","fact_date":"2025-12-05","cite_as":"公開資訊觀測站重大訊息：常廣（6730），2025-12-05 16:30，「公告本公司辦理股票初次上櫃過額配售內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6730-2025-12-05-1630-ahexl4","company_id":"6730","company":"常廣","market":"上櫃","industry":"生技醫療","date":"2025-12-05","time":"16:30:15","subject":"公告本公司股票初次上櫃前現金增資員工認購股款催繳事宜","clause":"第44款","fact_date":"2025-12-05","cite_as":"公開資訊觀測站重大訊息：常廣（6730），2025-12-05 16:30，「公告本公司股票初次上櫃前現金增資員工認購股款催繳事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6808-2025-12-05-1623-vyl6hj","company_id":"6808","company":"三鼎生技","market":"興櫃","industry":"生技醫療","date":"2025-12-05","time":"16:23:04","subject":"公告本公司董事會決議取得YD Bio Limited股權","clause":"第17款","fact_date":"2025-12-05","cite_as":"公開資訊觀測站重大訊息：三鼎生技（6808），2025-12-05 16:23，「公告本公司董事會決議取得YD Bio Limited股權」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7814-2025-12-05-1610-cptxtb","company_id":"7814","company":"海昌生技","market":"上櫃","industry":"生技醫療","date":"2025-12-05","time":"16:10:40","subject":"更正本公司112年及113年合併及個體、114年第2季合併財務報告附註暨iXBRL公告資訊，更正之申報資訊對本公司營業利益及稅(前)後淨利並無影響。","clause":"第44款","fact_date":"2025-12-05","cite_as":"公開資訊觀測站重大訊息：海昌生技（7814），2025-12-05 16:10，「更正本公司112年及113年合併及個體、114年第2季合併財務報告附註暨iXBRL公告資訊，更正之申報資訊對本公司營業利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2025-12-05-1605-1394c80","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2025-12-05","time":"16:05:39","subject":"本公司受邀參加永豐金證券2025年第四季產業論壇","clause":"第12款","fact_date":"2025-12-10","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2025-12-05 16:05，「本公司受邀參加永豐金證券2025年第四季產業論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6634-2025-12-05-1514-1v75o42","company_id":"6634","company":"欣耀","market":"興櫃","industry":"生技醫療","date":"2025-12-05","time":"15:14:32","subject":"公告本公司限制員工權利新股收回註銷減資變更登記完成","clause":"第35款","fact_date":"2025-12-05","cite_as":"公開資訊觀測站重大訊息：欣耀（6634），2025-12-05 15:14，「公告本公司限制員工權利新股收回註銷減資變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6703-2025-12-05-1436-3e4i9d","company_id":"6703","company":"軒郁","market":"上櫃","industry":"生技醫療","date":"2025-12-05","time":"14:36:24","subject":"公告本公司受邀參加統一綜合證券舉辦之法人說明會","clause":"第12款","fact_date":"2025-12-08","cite_as":"公開資訊觀測站重大訊息：軒郁（6703），2025-12-05 14:36，「公告本公司受邀參加統一綜合證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-12-05-1430-fmrme4","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-12-05","time":"14:30:24","subject":"本公司OBI-902 TROP2 ADC新藥獲美國食品藥物管理局審核通過治療胃癌的「孤兒藥」資格認定","clause":"第10款","fact_date":"2025-12-05","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-12-05 14:30，「本公司OBI-902 TROP2 ADC新藥獲美國食品藥物管理局審核通過治療胃癌的「孤兒藥」資格認定」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4183-2025-12-05-1357-17izuum","company_id":"4183","company":"福永生技","market":"上櫃","industry":"生技醫療","date":"2025-12-05","time":"13:57:20","subject":"公告本公司受邀參加114年12月8日台新證券舉辦之線上法人說明會","clause":"第12款","fact_date":"2025-12-08","cite_as":"公開資訊觀測站重大訊息：福永生技（4183），2025-12-05 13:57，「公告本公司受邀參加114年12月8日台新證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}